Repligen is committed to driving a smarter way to bioprocess through innovative Process Analytical Technology (PAT) that improves efficiency, performance, and process understanding across biopharmaceutical development and manufacturing. Through our PATsmart™ Analytical Solutions portfolio, Repligen delivers real-time, actionable insights that enable customers to manage and optimize their processes—not just measure them. By embedding intelligent analytics into critical bioprocess steps, PATsmart™ solutions help accelerate process time, improve consistency, reduce risk, and support data-driven decision-making from development through GMP manufacturing. Built on trusted Repligen innovation and deep bioprocess expertise, the PATsmart™ portfolio represents a more proactive approach to process analytics—shifting from delayed, manual measurements to real-time process understanding when and where it matters most. These solutions empower scientists and engineers to monitor, control, and optimize their processes with confidence, driving greater productivity and operational efficiency. Rooted in Repligen’s mission to inspire advances in bioprocessing and improve human health worldwide, PATsmart™ Analytical Solutions reinforce our leadership in Process Analytical Technology—helping customers move science faster through smarter data.
| Website | https://www.repligen.com/solutions/process-analytics/ |
| Revenue | $602.4 million |
| Employees | 40 (34 on RocketReach) |
| Founded | 1981 |
| Address | 685 Route 202/206, Bridgewater, New Jersey 08807, US |
| Industry | Biotechnology Research |
Looking for a particular Repligen-Process Analytical Technology employee's phone or email?
The Repligen-Process Analytical Technology annual revenue was $602.4 million in 2026.
Larry Russo is the Director International Sales and Support of Repligen-Process Analytical Technology.
34 people are employed at Repligen-Process Analytical Technology.
Repligen-Process Analytical Technology is based in Bridgewater, New Jersey.